The PDL1 expression on tumor cells can be upregulated by intrinsic oncogenic signaling pathways or by surrounding T cells through the IFNγ/STAT1/IRF1 pathway and chronic type I IFN exposure [7–9, 11]. This evidence concerns the gene IRF1 and neoplasm.